News
Explore The Oncology Institute's Q1 2025 earnings: 10% revenue growth, robust Dispensary performance, and a clear path to profitability by Q4.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback